What medications cause Stevens-Johnson syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Cause Stevens-Johnson Syndrome

The most common medications causing Stevens-Johnson syndrome (SJS) are anticonvulsants (carbamazepine, lamotrigine, phenytoin, phenobarbital), antibiotics (particularly sulfonamides), allopurinol, nevirapine, and oxicam-type NSAIDs. 1

High-Risk Medications

Anticonvulsants

  • Carbamazepine - Particularly high risk in patients of Southeast Asian descent with HLA-B*1502 genetic marker 1, 2
  • Lamotrigine - Associated with a relative risk >14 3
  • Phenytoin - Can cause serious skin reactions including SJS/TEN 4
  • Phenobarbital - Well-documented association 1

Antibiotics

  • Sulfamethoxazole and other sulfonamide antibiotics - Among the most common causes 1, 5
  • Aminopenicillins - Associated with increased risk 5
  • Cephalosporins - Documented risk 2
  • Quinolones - Associated with SJS/TEN 2, 5

Other High-Risk Medications

  • Allopurinol - Particularly at doses above 100mg daily 6, 5
  • Nevirapine - Very high risk with relative risk >22 1, 3
  • Oxicam-type NSAIDs - Strong association 1, 5
  • Sulfasalazine - Well-documented risk 1, 2

Medications with Emerging Risk

  • Sertraline - Relative risk of 11 3
  • Pantoprazole - Relative risk of 18 3
  • Tramadol - Relative risk of 20 3
  • Efavirenz - Associated with rash that can progress to SJS 1

Genetic Risk Factors

Certain genetic markers significantly increase the risk of SJS/TEN with specific medications:

  • HLA-B*1502 - Strong association with carbamazepine-induced SJS/TEN in patients of Southeast Asian ancestry 1, 4, 6
  • Genetic testing is recommended before prescribing carbamazepine to patients of Southeast Asian descent 2

Timing of Reaction

  • Most reactions occur within 5-28 days after starting the medication 1
  • Risk is highest during the first few weeks of drug intake 3
  • Shorter latency period may occur in patients with previous exposure to the same drug 1

Special Considerations

Children

  • In the pediatric population, both infections (particularly Mycoplasma pneumoniae) and medications are important triggers of SJS/TEN 1
  • Anticonvulsants and antibiotics are the most commonly implicated medications in children 1
  • Paracetamol (acetaminophen) and ibuprofen have unclear associations and may be confounders due to their use in treating prodromal symptoms 1

Risk Assessment

  • The SCORTEN score should be calculated within the first 24 hours of admission to predict mortality 1
  • Immediate withdrawal of the suspected medication is crucial as it decreases the risk of death 1

Prevention Strategies

  • Avoid high-risk medications when safer alternatives exist 3
  • Consider genetic testing for HLA-B*1502 in patients of Southeast Asian ancestry before prescribing carbamazepine 4, 6
  • In patients with a history of SJS/TEN, avoid not only the causative medication but also those with similar chemical structures 2

Diagnostic Challenges

  • Differentiating between early drug-associated rash and acute seroconversion can be difficult 1
  • Document all medications taken by the patient in the 2 months prior to symptom onset 1
  • Establish a timeline for each medication to help identify the culprit drug 1

SJS/TEN are severe and potentially fatal conditions with mortality rates of 1-5% for SJS and 25-35% for TEN 5. Early recognition of the causative medication and prompt discontinuation are essential for improving outcomes.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.